Filter
467
Text search:
antiretrovirals
Featured
Recommendations
24
New Publications
88
Language
Document type
No document type
326
Studies & Reports
53
Guidelines
44
Manuals
20
Infographics
11
Fact sheets
6
Training Material
3
Strategic & Response Plan
3
Online Courses
1
Countries / Regions
Kenya
19
Zambia
15
South Africa
15
Latin America and the Carribbean
15
Malawi
13
Rwanda
11
Nigeria
9
Uganda
9
Africa
9
Zimbabwe
8
Namibia
8
Global
8
Mozambique
7
Lesotho
7
Asia
7
Liberia
6
Ghana
6
India
6
Tanzania
6
Senegal
5
Cambodia
5
East and Southern Africa
5
Venezuela
5
Sierra Leone
4
Congo, Democratic Republic of
4
Ethiopia
4
Nepal
4
South–East Asia Region
4
Cameroon
3
Haiti
3
Philippines
3
Indonesia
3
Eswatini/ Swaziland
3
Brazil
3
Ukraine
3
Botswana
3
West and Central Africa
3
Russia
3
Burkina Faso
2
Thailand
2
Bangladesh
2
Benin
2
Central African Republic
2
Argentina
2
North Macedonia
2
Colombia
2
Angola
2
Myanmar / Burma
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Albania
2
Georgia
2
Guinea
1
Mali
1
Guinea-Bissau
1
Germany
1
Peru
1
Bolivia
1
Libya
1
Chile
1
Other region
1
Paraguay
1
Eastern Europe
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
41
Women & Child Health
19
Public Health
10
Key Resources
5
Pharmacy & Technologies
5
Capacity Building
3
Toolboxes
HIV
176
TB
32
Pharmacy
30
COVID-19
24
Caregiver
8
Mental Health
7
AMR
7
NTDs
3
Disability
2
Ebola
2
Conflict
2
Social Ethics
2
Health Financing Toolbox
2
Refugee
1
Global Health Education
1
Health Financing
1
NCDs
1
2014
Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean
COVID-19 is a disease caused by a new strain of coronavirus, a new coronavirus associated with the severe acute respiratory syndrome (SARS) viruses family and some coronaviruses associated with common cold.
There is still no evidence that persons living with HIV have a higher risk of contracting CO
...
Supply of essential medicines and health technologies (6 April 2020)
This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information and resources for decision-makers on measures to strengthen the health system response to C
...
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information from trustworthy sources. Information is presented in
...
This guideline document lays out the indicators for monitoring the 2016 Political Declaration on ending AIDS. The Global AIDS Monitoring (GAM) process has been often referenced as a benchmark for successful international accountability mechanisms.
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i
...
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной
...
Updated Guidelines
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o
...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions
...
2nd edition
